Trial Profile
Work Package 4: HPV Vaccination of Women in Screening Ages
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Apr 2019
Price :
$35
*
At a glance
- Drugs Human papillomavirus vaccine recombinant bivalent Japan Vaccine/MedImmune (Primary) ; Human papillomavirus vaccine recombinant quadrivalent Merck (Primary)
- Indications Cervical cancer
- Focus Therapeutic Use
- Acronyms CoheaHr-WP4
- 08 Apr 2019 Status changed from recruiting to completed.
- 06 Jul 2018 New trial record